Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-01-02 @ 2:58 PM
Study NCT ID:
NCT02338232
Status:
TERMINATED
Last Update Posted:
2024-05-01
First Post:
2015-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor:
Hackensack Meridian Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-05
First Submit QC Date:
None
Study First Post Date:
2015-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-04-05
Results First Submit QC Date:
None
Results First Post Date:
2024-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-05
Last Update Post Date:
2024-05-01
Last Update Post Date Type:
ACTUAL